Amyloidosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Megan Merlo (talk | contribs) (Created page with "__NOTOC__ {{Amyloidosis}} {{CMG}} {{AE}} {{PleaseHelp}} ==Overview== ==Other Diagnostic Studies== ==References== {{reflist|2}} Category:Disease Category:Rheumatolog...") |
Shyam Patel (talk | contribs) No edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Amyloidosis}} | {{Amyloidosis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{SHH}} | ||
{{ | |||
==Overview== | ==Overview== | ||
A tissue [[biopsy]] or fat [[aspirate]] should be done to confirm the presence or type of [[amyloid]] protein which is involved in the [[pathogenesis]] of the disease. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
* A tissue [[biopsy]] or fat [[aspirate]] should be done to confirm the presence or type of [[amyloid]] protein which is involved in the [[pathogenesis]] of the disease.<ref name="pmid24497558">{{cite journal |vauthors=Mahmood S, Palladini G, Sanchorawala V, Wechalekar A |title=Update on treatment of light chain amyloidosis |journal=Haematologica |volume=99 |issue=2 |pages=209–21 |date=February 2014 |pmid=24497558 |pmc=3912950 |doi=10.3324/haematol.2013.087619 |url=}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 19:30, 2 January 2019
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Amyloidosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Amyloidosis other diagnostic studies |
|
Risk calculators and risk factors for Amyloidosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
A tissue biopsy or fat aspirate should be done to confirm the presence or type of amyloid protein which is involved in the pathogenesis of the disease.
Other Diagnostic Studies
- A tissue biopsy or fat aspirate should be done to confirm the presence or type of amyloid protein which is involved in the pathogenesis of the disease.[1]
References
- ↑ Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.